Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (351-360 of 768) with videos related to

Pageof 77
Sort By:
Hematologic Pathology|January 1, 1993
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemiaJ Q Guo, C F Hirsch-Ginsberg, Y M Xian, et al.
Bone Marrow Transplantation|September 1, 1995
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipientsE Whimbey, R E Champlin, J A Englund, et al.
Bone Marrow Transplantation|June 29, 2010
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myelomaS M A Kazmi, R M Saliba, M Donato, et al.
Blood|June 1, 1992
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexateJ L Gajewski, L D Petz, L Calhoun, et al.
NPJ Digital Medicine|March 2, 2026
Development and explainable AI-driven characterization of a prognostic model for haploidentical transplantation outcomesRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Bone Marrow Transplantation|March 28, 2006
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapyN T Ueno, S Konoplev, T A Buchholz, et al.
Transplantation and Cellular Therapy|June 13, 2025
Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experienceJitesh D Kawedia, Victoria W Handy, Alan L Myers, et al.
Lancet (London, England)|June 15, 2007
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison studyMary Eapen, Pablo Rubinstein, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I TrialDean A Lee, Cecele J Denman, Gabriela Rondon, et al.
Annals of Internal Medicine|June 1, 1988
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletionJ M Goldman, R P Gale, M M Horowitz, et al.
Pageof 77

Showing results (351-360 of 768) with videos related to

Sort By:
Pageof 77
Hematologic Pathology|January 1, 1993
Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemiaJ Q Guo, C F Hirsch-Ginsberg, Y M Xian, et al.
Bone Marrow Transplantation|September 1, 1995
Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipientsE Whimbey, R E Champlin, J A Englund, et al.
Bone Marrow Transplantation|June 29, 2010
Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myelomaS M A Kazmi, R M Saliba, M Donato, et al.
Blood|June 1, 1992
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexateJ L Gajewski, L D Petz, L Calhoun, et al.
NPJ Digital Medicine|March 2, 2026
Development and explainable AI-driven characterization of a prognostic model for haploidentical transplantation outcomesRohtesh S Mehta, Yosra M Aljawai, Partow Kebriaei, et al.
Bone Marrow Transplantation|March 28, 2006
High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapyN T Ueno, S Konoplev, T A Buchholz, et al.
Transplantation and Cellular Therapy|June 13, 2025
Seizure prophylaxis and its impact on busulfan pharmacokinetics and dosing in a novel timed sequential protocol: MD Anderson experienceJitesh D Kawedia, Victoria W Handy, Alan L Myers, et al.
Lancet (London, England)|June 15, 2007
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison studyMary Eapen, Pablo Rubinstein, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2016
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I TrialDean A Lee, Cecele J Denman, Gabriela Rondon, et al.
Annals of Internal Medicine|June 1, 1988
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletionJ M Goldman, R P Gale, M M Horowitz, et al.
Pageof 77